Bioarctic granted Japanese patent for Parkinson’s disease candidate

Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.

List: The coolest names in biotech

Hairy beasts, volcanic material and space strolling stand out on a US list of the best biotech company names, and on a list of the coolest names for pharmaceuti...

Precision medicine centre: “Extensive activity on several fronts”

Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Deras samarbete ska ge ett pulvervaccin mot influensa

De bägge Uppsalabolagen Abera Bioscience och Orexo inleder ett samarbete för att ta fram vaccin i pulverform mot bland annat influensa.

KI’s freezer fiasco investigated: A chain of failures

A chain of combined technical and organisational shortcomings caused the freezer breakdown at the Karolinska Institute during the Christmas holidays, destroying...

The Swedish Research Council gets go-ahead for more long-term funding

Following a government decision, the Swedish Research Council will soon be able to approve ten-year grant periods for funding research infrastructure, which may...

Digital Temperature Sensors from ZEISS

New Metrology Expert Tip video.

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Anna Törner: ”Mamma, tror du att du kommer att gifta om dig?”

”Jag inser att min hjärna är på väg ned i det statistiska kaninhålet, där frågor besvaras med punktskattningar och konfidensintervall.” Det skriver Anna Törner i en krönika.

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

A new giant among our microscopes

Two technologies in one machine.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!

Norwegian company wins bidding battle for Sensidose

The lengthy battle to acquire medical device company Sensidose is apparently over. Generic medicines company EQL Pharma is pulling out, selling its shares and l...

Smart att annonsera på Google

Idag när internet är en stor del av de flestas vardag, så gäller det att som företag synas där på ett bra sätt. Dels är det bra om man har en egen hemsida, som ...

Major investment in women’s health – for a more equal healthcare system

”The regional differences need to decrease and the long-term supply of midwives and other professions needs to be secured,” write Acko Ankarberg Johansson and D...

Pharma Outsourcing – Find the Right Partner (2026)

Läkemedelsbolag skänker nödläkemedel till marburgdrabbade Rwanda

Gilead Sciences har beslutat att skänka 5 000 doser av antivirusläkemedlet remdesivir till Rwanda för nödanvändning under det pågående utbrottet av den fruktade...

An increasing number of people are falling ill with TBE – “Much more research is needed”

Tick-borne meningitis, or TBE, is an increasingly common disease in Sweden. Currently, there is a vaccine against the disease but no drugs. Researcher Anna Över...

Novo Nordisk buys drug candidate in billion dollar deal

The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...